Interleukin Inhibitors Market worth $151.28 billion by 2035
The global Interleukin Inhibitors Market has emerged as one of the most dynamic segments within the biologics and immunotherapy industry. The market was valued at approximately USD 37.72 billion in 2025 and is anticipated to reach nearly USD 151.28 billion by 2035, expanding at a CAGR of 14.9% during the forecast period from 2026 to 2035. The market expansion is being supported by increasing prevalence of autoimmune and inflammatory disorders, rapid biologics innovation, and rising adoption of targeted therapies in clinical practice.
